Literature DB >> 10430859

Potent urea and carbamate inhibitors of soluble epoxide hydrolases.

C Morisseau1, M H Goodrow, D Dowdy, J Zheng, J F Greene, J R Sanborn, B D Hammock.   

Abstract

The soluble epoxide hydrolase (sEH) plays a significant role in the biosynthesis of inflammation mediators as well as xenobiotic transformations. Herein, we report the discovery of substituted ureas and carbamates as potent inhibitors of sEH. Some of these selective, competitive tight-binding inhibitors with nanomolar K(i) values interacted stoichiometrically with the homogenous recombinant murine and human sEHs. These inhibitors enhance cytotoxicity of trans-stilbene oxide, which is active as the epoxide, but reduce cytotoxicity of leukotoxin, which is activated by epoxide hydrolase to its toxic diol. They also reduce toxicity of leukotoxin in vivo in mice and prevent symptoms suggestive of acute respiratory distress syndrome. These potent inhibitors may be valuable tools for testing hypotheses of involvement of diol and epoxide lipids in chemical mediation in vitro or in vivo systems.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430859      PMCID: PMC17696          DOI: 10.1073/pnas.96.16.8849

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Kinetic and chemical mechanism of epoxide hydrolase.

Authors:  R N Armstrong
Journal:  Drug Metab Rev       Date:  1999-02       Impact factor: 4.518

2.  Affinity purification of cytosolic epoxide hydrolase using derivatized epoxy-activated Sepharose gels.

Authors:  R N Wixtrom; M H Silva; B D Hammock
Journal:  Anal Biochem       Date:  1988-02-15       Impact factor: 3.365

3.  The graphical determination of K m and K i .

Authors:  M Dixon
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

4.  cDNA cloning and expression of a soluble epoxide hydrolase from human liver.

Authors:  J K Beetham; T Tian; B D Hammock
Journal:  Arch Biochem Biophys       Date:  1993-08-15       Impact factor: 4.013

5.  Chalcone oxides--potent selective inhibitors of cytosolic epoxide hydrolase.

Authors:  C A Mullin; B D Hammock
Journal:  Arch Biochem Biophys       Date:  1982-07       Impact factor: 4.013

6.  Inhibition of cytosolic epoxide hydrolase by trans-3-phenylglycidols.

Authors:  E C Dietze; E Kuwano; J Casas; B D Hammock
Journal:  Biochem Pharmacol       Date:  1991-08-22       Impact factor: 5.858

7.  Cardiovascular effects of leukotoxin (9, 10-epoxy-12-octadecenoate) and free fatty acids in dogs.

Authors:  A Fukushima; M Hayakawa; S Sugiyama; M Ajioka; T Ito; T Satake; T Ozawa
Journal:  Cardiovasc Res       Date:  1988-03       Impact factor: 10.787

8.  Molecular cloning and expression of murine liver soluble epoxide hydrolase.

Authors:  D F Grant; D H Storms; B D Hammock
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

9.  Leukotoxin, 9,10-epoxy-12-octadecenoate causes pulmonary vasodilation in rats.

Authors:  T Ishizaki; H Takahashi; T Ozawa; S W Chang; N F Voelkel
Journal:  Am J Physiol       Date:  1995-01

10.  Spectrophotometric substrates for cytosolic epoxide hydrolase.

Authors:  E C Dietze; E Kuwano; B D Hammock
Journal:  Anal Biochem       Date:  1994-01       Impact factor: 3.365

View more
  110 in total

1.  Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase.

Authors:  M A Argiriadi; C Morisseau; B D Hammock; D W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 2.  Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

Authors:  Hong C Shen; Bruce D Hammock
Journal:  J Med Chem       Date:  2012-01-17       Impact factor: 7.446

3.  An immunoassay to evaluate human/environmental exposure to the antimicrobial triclocarban.

Authors:  Ki Chang Ahn; Takeo Kasagami; Hsing-Ju Tsai; Nils Helge Schebb; Temitope Ogunyoku; Shirley J Gee; Thomas M Young; Bruce D Hammock
Journal:  Environ Sci Technol       Date:  2011-12-08       Impact factor: 9.028

4.  Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.

Authors:  Stevan Pecic; Shi-Xian Deng; Christophe Morisseau; Bruce D Hammock; Donald W Landry
Journal:  Bioorg Med Chem Lett       Date:  2011-10-28       Impact factor: 2.823

5.  11,12,20-Trihydroxy-eicosa-8(Z)-enoic acid: a selective inhibitor of 11,12-EET-induced relaxations of bovine coronary and rat mesenteric arteries.

Authors:  Ishfaq A Bukhari; Abdul Jabbar Shah; Kathryn M Gauthier; Katherine A Walsh; Sreenivasulu Reddy Koduru; John D Imig; John R Falck; William B Campbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

Review 6.  Role of epoxide hydrolases in lipid metabolism.

Authors:  Christophe Morisseau
Journal:  Biochimie       Date:  2012-06-18       Impact factor: 4.079

7.  Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.

Authors:  Vladimir Burmistrov; Christophe Morisseau; Kin Sing Stephen Lee; Diyala S Shihadih; Todd R Harris; Gennady M Butov; Bruce D Hammock
Journal:  Bioorg Med Chem Lett       Date:  2014-03-20       Impact factor: 2.823

8.  Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability.

Authors:  Vladimir Burmistrov; Christophe Morisseau; Todd R Harris; Gennady Butov; Bruce D Hammock
Journal:  Bioorg Chem       Date:  2017-12-30       Impact factor: 5.275

Review 9.  The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain.

Authors:  Sean D Kodani; Bruce D Hammock
Journal:  Drug Metab Dispos       Date:  2015-03-11       Impact factor: 3.922

10.  Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.

Authors:  Jeffrey J Olearczyk; Jeffrey E Quigley; Bradford C Mitchell; Tatsuo Yamamoto; In-Hae Kim; John W Newman; Ayala Luria; Bruce D Hammock; John D Imig
Journal:  Clin Sci (Lond)       Date:  2009-01       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.